$IR

Ingersoll Rand Inc.

0
0
1

No SEC Form 4 filings for $IR in the last 30 days.

See all $IR insider activity →

Is Ingersoll Rand Stock Underperforming the S&P 500?

Ingersoll Rand (IR) has underperformed rival GE Vernova (GEV), which gained 46.5% year-to-date. Analysts rate IR as a 'Moderate Buy' with a mean price target of $95.54, suggesting 31% upside.

Is Ingersoll Rand Inc (IR) a Bargain After 3.1% Drop? GF Value S

Ingersoll Rand Inc (IR) shares fell 3.1% to $74.64 on September 1, 2026, within a 52-week range of $68.07-$100.96. The stock is undervalued by 20.4% according to GF Value™, with a GF Score™ of 88/100. Insiders sold $59.4M in shares vs. $1.0M in purchases over the past year. Current P/E is 30.7x, below its 5-year median of 41.6x.

IR sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning IR (Ingersoll Rand Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent IR coverage spans earnings, financial news and insider activity.

What's driving IR

AlphAI scores every news story that mentions IR with an AI model for sentiment and relevance, and aggregates insider trades from Ingersoll Rand Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $IR

Score
$IRMedAI 8/10

Ingersoll Rand Q1 Results: Net profit rises 20% YoY to ₹70.46 crore

Ingersoll-Rand (India) Ltd reported Q1 ended June 30, 2026 net profit of ₹70.46 crore, up 19.5% year on year from ₹58.98 crore. Revenue from operations rose 20.3% to ₹379.46 crore, with total income up 19.8% to ₹389.29 crore. Board approved unaudited results on Aug 13, 2026; Deloitte Haskins & Sells issued an unmodified review conclusion.

$IRMed

Will Stronger Q2 2026 Results and Higher Guidance Reshape Ingersoll Rand's (IR) Capital Return Narrative?

Ingersoll Rand (IR) reported Q2 2026 sales of $2,048.8 million and net income of $256.8 million, with stronger earnings in the first half. The company updated full-year 2026 revenue growth guidance to 4.5% to 6.5%. It also said it has completed over $2.08 billion in share repurchases since 2021 and made acquisitions to expand aftermarket capabilities.

$IRMedAI 8/10

Ingersoll Rand (IR) Q2 2026 Earnings Call Transcript

Ingersoll Rand (IR) reported Q2 2026 revenue of $2,048.8 million, up 9% YoY, with organic revenue growth of 4.1%. Adjusted EBITDA was $519.9 million, up 2%, while margin fell 160 bps to 25.4%. Adjusted EPS rose 7% to $0.86. The company raised full-year 2026 revenue guidance to 4.5% to 6.5% growth and maintained adjusted EBITDA guidance at $2.13B to $2.19B.

Ingersoll Rand’s Q2 Earnings Call: Our Top 5 Analyst Questions

Ingersoll Rand reported Q2 revenue of $2.05B versus $1.96B estimates and adjusted EPS of $0.86 versus $0.83, citing broad organic growth and resilient compressor and life sciences demand. Management reiterated full-year adjusted EPS guidance of $3.51 and EBITDA guidance of $2.16B. Margin pressure from inflation and incentives was offset by aftermarket services and operational discipline.

Related tickers